The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Aug 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Aug 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Jun 20, 2024 | Rubino Stephen | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Pomerantz Roger | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Pomerantz Roger | Director | Grant(A) | 19K | — | $0 |
| Jun 20, 2024 | Barlow Jane F | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Simon Barry J. | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Darcy Thomas E | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Murphy Samuel Lafayette | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Chung Jane | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Borellini Flavia | Director | Grant(A) | 50K | — | $0 |
| Jun 20, 2024 | Royston Ivor | Director | Grant(A) | 50K | — | $0 |
| May 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| May 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| May 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| May 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| May 14, 2024 | Faerm Michael E. | Chief Financial Officer | Grant(A) | 500K | — | $0 |
| Mar 12, 2024 | Chevallard Daniel R. | CFO and COO | Grant(A) | 200K | — | $0 |
| Mar 12, 2024 | Cohen Darrel P. | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Mar 12, 2024 | Rothera Mark | President and CEO, Director | Grant(A) | 475K | — | $0 |
| Feb 27, 2024 | Chevallard Daniel R. | CFO and COO | Sell(S) | 3K | $0.73 | $2K |
| Feb 25, 2024 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Feb 25, 2024 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Feb 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Feb 25, 2024 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Feb 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Feb 25, 2024 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Dec 1, 2023 | Rothera Mark | President and CEO, Director | Buy(P) | 48K | $0.49 | $23K |
| Nov 30, 2023 | Rothera Mark | President and CEO, Director | Buy(P) | 52K | $0.49 | $26K |
| Nov 28, 2023 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $0.50 | $2K |
| Nov 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Nov 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Aug 28, 2023 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $1.45 | $5K |
| Aug 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Aug 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Aug 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Aug 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Aug 16, 2023 | Cohen Darrel P. | Chief Medical Officer | Grant(A) | 235K | — | $0 |
| Aug 16, 2023 | Cohen Darrel P. | Chief Medical Officer | Grant(A) | 265K | — | $0 |
| Aug 16, 2023 | Pomerantz Roger | Director | Grant(A) | 15K | — | $0 |
| Jun 8, 2023 | Barlow Jane F | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Borellini Flavia | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Chung Jane | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Darcy Thomas E | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Murphy Samuel Lafayette | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Pomerantz Roger | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Royston Ivor | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Rubino Stephen | Director | Grant(A) | 40K | — | $0 |
| Jun 8, 2023 | Simon Barry J. | Director | Grant(A) | 40K | — | $0 |
| May 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| May 25, 2023 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $1.42 | $5K |
| May 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| May 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| May 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| May 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| May 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Mar 16, 2023 | Chevallard Daniel R. | CFO and COO | Grant(A) | 200K | — | $0 |
| Mar 16, 2023 | Rojkjaer Lisa | Chief Medical Officer | Grant(A) | 150K | — | $0 |
| Mar 16, 2023 | Rothera Mark | President and CEO, Director | Grant(A) | 400K | — | $0 |
| Feb 27, 2023 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $1.68 | $6K |
| Feb 27, 2023 | Rojkjaer Lisa | Chief Medical Officer | Sell(S) | 2K | $1.68 | $4K |
| Feb 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Feb 25, 2023 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Feb 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Feb 25, 2023 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Feb 25, 2023 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Feb 25, 2023 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Feb 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Feb 25, 2023 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 28, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell(S) | 2K | $2.72 | $6K |
| Nov 28, 2022 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $2.72 | $10K |
| Nov 25, 2022 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 25, 2022 | Royston Ivor | Director | Option exercise(M) | 25K | — | $0 |
| Nov 25, 2022 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2022 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Nov 25, 2022 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Nov 25, 2022 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Nov 25, 2022 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Nov 25, 2022 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
| Sep 19, 2022 | Rothera Mark | President and CEO, Director | Grant(A) | 1.4M | — | $0 |
| Aug 26, 2022 | Rojkjaer Lisa | Chief Medical Officer | Sell(S) | 2K | $4.01 | $9K |
| Aug 26, 2022 | Chevallard Daniel R. | CFO and COO | Sell(S) | 4K | $4.02 | $15K |
| Aug 26, 2022 | Royston Ivor | CEO & President, Director | Sell(S) | 13K | $4.01 | $54K |
| Aug 25, 2022 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Aug 25, 2022 | Rojkjaer Lisa | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Aug 25, 2022 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2022 | Pomerantz Roger | Director | Option exercise(M) | 9K | — | $0 |
| Aug 25, 2022 | Chevallard Daniel R. | CFO and COO | Option exercise(M) | 7K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).